CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (482,508)
Adjustments to reconcile net loss to net cash used in operating activities:
Trust income reinvested in Trust Account	(691,470)
Changes in operating assets and liabilities:
Prepaid expenses	(386,229)
Accounts payable and accrued expenses	333,432
Net cash used in operating activities	(1,226,775)
Cash flows from investing activities:
Principal deposited in Trust Account	(690,000,000)
Cash withdrawn from Trust	652,000
Net cash used in investing activities	(689,348,000)
Cash flows from financing activities:
Proceeds from sale of private placement warrants	15,050,000
Proceeds from sale of units	690,000,000
Payment of underwriters' discount	(13,800,000)
Payment of offering costs	(649,398)
Advances received from Promissory note	460,885
Repayment of advances received from Promissory note	(230,885)
Net cash provided by financing activities	690,830,602
Increase in cash during period	255,827
Cash at end of period	255,827
Supplemental disclosure of non-cash investing and financing activities:
Deferred underwriting compensation	24,150,000
Class A common stock subject to possible redemption	660,903,790
Offering costs paid by sponsor in exchange for founder shares	25,000
Deferred offering costs included in accounts payable and accrued expenses	$ 64,294